3SIXTY PHARMA SOLUTIONS
LIVE

Serial Number

97869217

Owner

3Sixty Pharma Solutions LLC.

First Use Date

Jan 1, 2018

Filing Date

Apr 2, 2023

Add to watchlist:

No watchlists yet
View on USPTO

3SIXTY PHARMA SOLUTIONS Trademark

Serial Number: 97869217 • Registration: 8055180

3SIXTY PHARMA SOLUTIONS is a trademark filed by 3Sixty Pharma Solutions LLC. on April 2, 2023. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

3Sixty Pharma Solutions LLC.

1950 Butler Pike, #175
Conshohocken, PA 19428

Entity Type: 16

Trademark Details

Filing Date

April 2, 2023

Registration Date

December 9, 2025

First Use Anywhere

January 1, 2018

First Use in Commerce

January 1, 2018

Published for Opposition

October 21, 2025

Goods & Services

Regulatory submission management in the field of medical research, clinical and non-clinical studies, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies

Consulting services for others in the field of design, planning, and implementation project management of medical, scientific and data analysis research services for others; Scientific research in the nature of conducting and analyzing clinical trials for others in the pharmaceutical, biotechnology, medical device, and life sciences fields; pharmaceutical drug evaluation, research, and development services; biotechnology product evaluation, research, and development services; medical device evaluation, research, and development services; life science technology evaluation, research, and development services, namely, developing clinical and pre-clinical trial designs and methodologies; consulting services in the area of pharmaceutical, biotechnology, and medical device clinical testing; extended clinical research services for others, namely, oversight of computerized data management of clinical trials, biostatistical analysis; preclinical research and development planning, evaluation, and execution; repairing flawed clinical trials and dossiers, strategic clinical research portfolio management, and oversight of biosurveillance monitoring; providing regulatory-compliant technical writing in the field of medical research, clinical and non-clinical studies; consulting services in the field of contract clinical research, and contract product development; Internet development, design and consulting services for others, namely, creating websites featuring blogs about medical and pharmaceutical information related to therapeutics and illnesses and disease

Development of printed educational materials of others in the field of life sciences and scientific research information to share with physicians and other health care professionals, patients, and medical, pharmaceutical and biotechnology companies

Regulatory compliance consulting in the field of clinical research and medical product development

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 9, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 9, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 21, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 21, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 15, 2025 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Sep 23, 2025 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 28, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 23, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 22, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 25, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 25, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 25, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 26, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 26, 2025 CRFA
ASSIGNED TO LIE
Aug 28, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 23, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 16, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 16, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 16, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 28, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 27, 2023 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2023 NWOS
NEW APPLICATION ENTERED
Apr 5, 2023 NWAP